Progressive loss of conserved spike protein neutralizing antibody sites in Omicron sublineages is balanced by preserved T cell immunity
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Progressive loss of conserved spike protein neutralizing antibody sites in Omicron sublineages is balanced by preserved T cell immunity
Authors
Keywords
-
Journal
Cell Reports
Volume 42, Issue 8, Pages 112888
Publisher
Elsevier BV
Online
2023-08-01
DOI
10.1016/j.celrep.2023.112888
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Early computational detection of potential high-risk SARS-CoV-2 variants
- (2023) Karim Beguir et al. COMPUTERS IN BIOLOGY AND MEDICINE
- Fc-γR-dependent antibody effector functions are required for vaccine-mediated protection against antigen-shifted variants of SARS-CoV-2
- (2023) Samantha R. Mackin et al. Nature Microbiology
- SARS-CoV-2 vaccination induces immunological T cell memory able to cross-recognize variants from Alpha to Omicron
- (2022) Alison Tarke et al. CELL
- Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies
- (2022) Yunlong Cao et al. NATURE
- The T cell immune response against SARS-CoV-2
- (2022) Paul Moss NATURE IMMUNOLOGY
- Ancestral SARS-CoV-2-specific T cells cross-recognize the Omicron variant
- (2022) Yu Gao et al. NATURE MEDICINE
- Neutralization of SARS-CoV-2 Omicron by BNT162b2 mRNA vaccine–elicited human sera
- (2022) Alexander Muik et al. SCIENCE
- Divergent SARS CoV-2 Omicron-reactive T- and B cell responses in COVID-19 vaccine recipients
- (2022) Corine H. GeurtsvanKessel et al. Science Immunology
- Neutralizing immunity in vaccine breakthrough infections from the SARS-CoV-2 Omicron and Delta variants
- (2022) Venice Servellita et al. CELL
- The Impact of Evolving SARS-CoV-2 Mutations and Variants on COVID-19 Vaccines
- (2022) Gary McLean et al. mBio
- Omicron BA.1 breakthrough infection drives cross-variant neutralization and memory B cell formation against conserved epitopes
- (2022) Jasmin Quandt et al. Science Immunology
- Correlates of protection against SARS ‐ CoV ‐2 infection and COVID‐19 disease
- (2022) David Goldblatt et al. IMMUNOLOGICAL REVIEWS
- Evolution of the SARS‐CoV‐2 omicron variants BA.1 to BA.5: Implications for immune escape and transmission
- (2022) Lok Bahadur Shrestha et al. REVIEWS IN MEDICAL VIROLOGY
- Neutralization of Omicron BA.1, BA.2, and BA.3 SARS-CoV-2 by 3 doses of BNT162b2 vaccine
- (2022) Chaitanya Kurhade et al. Nature Communications
- The SARS-CoV-2 Delta variant induces an antibody response largely focused on class 1 and 2 antibody epitopes
- (2022) Allison J. Greaney et al. PLoS Pathogens
- The Robustness of Cellular Immunity Determines the Fate of SARS-CoV-2 Infection
- (2022) Esther Moga et al. Frontiers in Immunology
- Antigenic characterization of the SARS-CoV-2 Omicron subvariant BA.2.75
- (2022) Qian Wang et al. Cell Host & Microbe
- Further humoral immunity evasion of emerging SARS-CoV-2 BA.4 and BA.5 subvariants
- (2022) Fanchong Jian et al. LANCET INFECTIOUS DISEASES
- Neutralisation sensitivity of the SARS-CoV-2 omicron BA.2.75 sublineage
- (2022) Henning Gruell et al. LANCET INFECTIOUS DISEASES
- Neutralization of SARS-CoV-2 Omicron BA.2.75 after mRNA-1273 Vaccination
- (2022) Xiaoying Shen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Adaptive immunity to SARS-CoV-2 infection: A systematic review
- (2022) Marcos Jessé Abrahão Silva et al. Frontiers in Immunology
- Omicron BA.2 breakthrough infection enhances cross-neutralization of BA.2.12.1 and BA.4/BA.5
- (2022) Alexander Muik et al. Science Immunology
- Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants
- (2022) Qian Wang et al. CELL
- Omicron sublineage BQ.1.1 resistance to monoclonal antibodies
- (2022) Prerna Arora et al. LANCET INFECTIOUS DISEASES
- Exposure to BA.4/5 S protein drives neutralization of Omicron BA.1, BA.2, BA.2.12.1, and BA.4/5 in vaccine-experienced humans and mice
- (2022) Alexander Muik et al. Science Immunology
- Adaptive immunity to SARS-CoV-2 and COVID-19
- (2021) Alessandro Sette et al. CELL
- Neutralization of SARS-CoV-2 lineage B.1.1.7 pseudovirus by BNT162b2 vaccine–elicited human sera
- (2021) Alexander Muik et al. SCIENCE
- CoV-AbDab: the Coronavirus Antibody Database
- (2020) Matthew I J Raybould et al. BIOINFORMATICS
- Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity
- (2020) Carolyn Rydyznski Moderbacher et al. CELL
- SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies
- (2020) Christopher O. Barnes et al. NATURE
- Nextstrain: real-time tracking of pathogen evolution
- (2018) James Hadfield et al. BIOINFORMATICS
- A Vesicular Stomatitis Virus Replicon-Based Bioassay for the Rapid and Sensitive Determination of Multi-Species Type I Interferon
- (2011) Marianne Berger Rentsch et al. PLoS One
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now